货号:A708952
同义名:
Rhosin (hydrochloride); Rhosin hydrochloride
Rhosin HCl是一种特异性的 RhoA 抑制剂,其亲和力约为 0.4 μM Kd,且不干扰 Cdc42 或 Rac1 的结合。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Cdc42-subclass ↓ ↑ | Rac ↓ ↑ | Rho-subclass ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZCL278 |
++
Cdc42 GTPase, Kd: 11.4 μM |
98% | |||||||||||||||||
| ML141 |
+++
cdc42, IC50: 200 nM |
99%+ | |||||||||||||||||
| NSC 23766 3HCl |
+
Rac GTPase, IC50: 50 μM |
98% | |||||||||||||||||
| EHop-016 |
+++
Rac1, IC50: 1.1 μM |
98% | |||||||||||||||||
| Azathioprine | ✔ | 98% | |||||||||||||||||
| EHT 1864 |
++++
Rac3, Kd: 50 nM Rac1, Kd: 40 nM |
99%+ | |||||||||||||||||
| Zoledronic Acid | ✔ | Ras | 98% | ||||||||||||||||
| CCG-1423 | ✔ | 99%+ | |||||||||||||||||
| CCG-203971 | ✔ | 99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | RhoA is a ubiquitously expressed cytoplasmic protein that belongs to the family of small GTPases. RhoA acts as a molecular switch that is activated in response to binding of chemokines, cytokines, and growth factors, and via mDia and the ROCK signaling cascade regulates the activation of cytoskeletal proteins, and other factors[3].Rhosin hydrochloride is a potent, specific RhoA subfamily Rho GTPases inhibitor. Rhosin hydrochloride specifically binds to RhoA to inhibit RhoA-GEF interaction with a Kd of ~ 0.4 uM, and does not interact with Cdc42 or Rac1, nor the GEF, LARG. Rhosin hydrochloride induces cell apoptosis[4]. In cells, Rhosin specifically inhibited RhoA activity and RhoA-mediated cellular function without affecting Cdc42 or Rac1 signaling activities. By suppressing RhoA or RhoC activity, Rhosin could inhibit mammary sphere formation by breast cancer cells, suppress invasion of mammary epithelial cells, and induce neurite outgrowth of PC12 cells in synergy with NGF. Rhosin HCL dose-dependently reduces RhoA and p-MLC1 activities of MCF7 cell-derived mammospheres with an EC50 ~30-50 μM, and causes decreased size and reduced number of mammospheres in MCF7 cells[5]. Rhosin HCL promotes stress resiliency through enhancing D1-MSN plasticity and reducing hyperexcitability. Rhosin hydrochloride dose-dependently reduces RhoA and p-MLC1 activities of MCF7 cell-derived mammospheres with an EC50 ~30-50 μM, and causes decreased size and reduced number of mammospheres in MCF7 cells. Rhosin (40 mg/kg; i.p.) treatment prevents social avoidance caused by social defeat stress. Rhosin also blocks sucrose preference deficits induced by defeat in C57Bl6/J (Jackson) mice. Rhosin (30 µM; bilateral, intra- Nucleus Accumbens (NAc) infusions) attenuates stress-induced social avoidance. Rhosin blocks stress-induced hyperexcitability in NAc dopamine 1 receptor medium spiny neurons (D1-MSNs). Rhosin prevents decreased excitatory transmission on NAc D1-MSNs. Rhosin enhances spine density in defeat mice[6]. |
| Concentration | Treated Time | Description | References | |
| Rat bone marrow mesenchymal stem cells | 20 µM | 14 days | To investigate the effect of Rhosin on the proliferation and osteogenic differentiation of BMSC under dynamic culture conditions. Results showed that Rhosin inhibited the proliferation and osteogenic differentiation of BMSC. | Bioeng Transl Med. 2023 Mar 17;8(3):e10509. |
| Human lung microvascular endothelial cells (HLMVEC) | 30 µM | 2 hours | To investigate the inhibitory effect of Rhosin on 2-ClHA-induced endothelial barrier dysfunction. Results showed that Rhosin pretreatment significantly inhibited the barrier dysfunction caused by 2-ClHA. | Redox Biol. 2025 May;82:103596. |
| HEK293 cells | 5 µM, 10 µM, 15 µM, 30 µM | 2 hours | To investigate the effect of Rhosin on F/G-actin ratio in GNE mutant cells. Results showed that treatment with 10µM Rhosin restored the F/G-actin ratio in GNE mutant cells. | Front Cell Dev Biol. 2021 Mar 18;9:603742. |
| Human platelets | 20 µM | 2 min | Blocked the phosphorylation of the myosin light chain (p-MLC) | Int J Mol Sci. 2023 Feb 19;24(4):4167. |
| 4T1 cells | 1-50 µM | 3 days | Rhosin inhibited RhoA and RhoC activation, and suppressed YAP nuclear localization, but did not affect ERK1/2, Akt, or NF-κB activation. | Biomedicines. 2021 Jan 4;9(1):35. |
| B16BL6 cells | 1-50 µM | 3 days | Rhosin inhibited RhoA and RhoC activation, and suppressed YAP nuclear localization, but did not affect ERK1/2, Akt, or NF-κB activation. | Biomedicines. 2021 Jan 4;9(1):35. |
| PC-3 cells | 30 µM | RhoA inhibitor Rhosin diminished CRMP4a shRNA-induced increase of cancer cell migration | Cancer Biol Ther. 2018;19(12):1193-1203. |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6J mice and Balb/c mice | B16BL6 and 4T1 lung metastasis model | Intraperitoneal injection | 10 mg/kg or 30 mg/kg | Daily for 14 days | Rhosin reduced the number of lung metastatic nodules in B16BL6 and 4T1 cells in a dose-dependent manner. | Biomedicines. 2021 Jan 4;9(1):35. |
| Mice | Chronic social defeat stress model | Intraperitoneal injection | 40 mg/kg | Once daily for 7 days | To evaluate the effects of Rhosin on behavioral and physiological changes induced by chronic social defeat stress, it was found that Rhosin prevented social avoidance and reduced sucrose preference caused by CSDS, and enhanced spine density in D1-MSNs. | Biol Psychiatry. 2019 Jun 15;85(12):1001-1010 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.53mL 0.51mL 0.25mL |
12.66mL 2.53mL 1.27mL |
25.33mL 5.07mL 2.53mL |
|
| CAS号 | 1281870-42-5 |
| 分子式 | C20H19ClN6O |
| 分子量 | 394.86 |
| SMILES Code | O=C(N/N=C/C1=CC=C2N=CC=NC2=C1)[C@H](N)CC3=CNC4=C3C=CC=C4.[H]Cl |
| MDL No. | MFCD18794648 |
| 别名 | Rhosin (hydrochloride); Rhosin hydrochloride; G04; G04 hydrochloride |
| 运输 | 蓝冰 |
| InChI Key | SFRGBDFQSLZYLF-GRYLRVQNSA-N |
| Pubchem ID | 52998412 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 50 mg/mL(126.63 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 15 mg/mL(37.99 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1